GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $377,000 | -12.3% | 8,672 | -12.1% | 0.02% | -5.3% |
| Q1 2022 | $430,000 | +107.7% | 9,861 | +109.8% | 0.02% | +111.1% |
| Q4 2021 | $207,000 | +14.4% | 4,700 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $181,000 | +5.2% | 4,747 | +9.8% | 0.01% | 0.0% |
| Q2 2021 | $172,000 | +4.9% | 4,323 | -6.2% | 0.01% | 0.0% |
| Q1 2021 | $164,000 | -16.3% | 4,608 | -13.7% | 0.01% | -25.0% |
| Q4 2020 | $196,000 | +20.2% | 5,337 | +22.9% | 0.01% | +9.1% |
| Q3 2020 | $163,000 | -23.5% | 4,342 | -16.9% | 0.01% | -26.7% |
| Q2 2020 | $213,000 | -2.3% | 5,224 | -9.1% | 0.02% | -21.1% |
| Q1 2020 | $218,000 | -24.6% | 5,744 | -6.5% | 0.02% | -5.0% |
| Q4 2019 | $289,000 | +21.9% | 6,145 | +10.5% | 0.02% | +5.3% |
| Q3 2019 | $237,000 | +5.3% | 5,560 | -1.0% | 0.02% | 0.0% |
| Q2 2019 | $225,000 | -21.6% | 5,616 | -18.3% | 0.02% | -26.9% |
| Q1 2019 | $287,000 | -64.1% | 6,872 | -67.2% | 0.03% | -68.7% |
| Q4 2018 | $800,000 | +8.3% | 20,946 | +13.8% | 0.08% | +18.6% |
| Q3 2018 | $739,000 | +2.2% | 18,399 | +2.6% | 0.07% | -1.4% |
| Q2 2018 | $723,000 | -18.3% | 17,940 | -20.8% | 0.07% | -21.1% |
| Q1 2018 | $885,000 | +59.5% | 22,657 | +44.9% | 0.09% | +55.2% |
| Q4 2017 | $555,000 | -43.6% | 15,636 | -35.5% | 0.06% | -50.8% |
| Q3 2017 | $984,000 | +6.3% | 24,225 | +12.8% | 0.12% | -2.5% |
| Q2 2017 | $926,000 | +5.2% | 21,479 | +2.9% | 0.12% | -6.2% |
| Q1 2017 | $880,000 | +6.2% | 20,883 | -3.0% | 0.13% | -5.1% |
| Q4 2016 | $829,000 | -5.6% | 21,518 | +5.7% | 0.14% | -12.3% |
| Q3 2016 | $878,000 | +44.2% | 20,348 | +44.9% | 0.16% | +30.3% |
| Q2 2016 | $609,000 | -2.2% | 14,044 | -8.5% | 0.12% | -7.8% |
| Q1 2016 | $623,000 | +8.7% | 15,352 | +8.1% | 0.13% | +4.0% |
| Q4 2015 | $573,000 | +4.0% | 14,204 | -0.8% | 0.12% | +2.5% |
| Q3 2015 | $551,000 | -10.1% | 14,322 | -2.6% | 0.12% | -0.8% |
| Q2 2015 | $613,000 | +13.5% | 14,710 | +25.6% | 0.12% | +8.0% |
| Q1 2015 | $540,000 | +51.3% | 11,710 | +40.2% | 0.11% | +36.1% |
| Q4 2014 | $357,000 | +32.7% | 8,352 | +42.8% | 0.08% | +23.9% |
| Q3 2014 | $269,000 | +976.0% | 5,847 | +1144.0% | 0.07% | +1016.7% |
| Q2 2014 | $25,000 | 0.0% | 470 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $25,000 | +78.6% | 470 | +74.1% | 0.01% | +40.0% |
| Q4 2013 | $14,000 | -58.8% | 270 | -60.0% | 0.01% | -61.5% |
| Q3 2013 | $34,000 | 0.0% | 675 | +0.3% | 0.01% | -7.1% |
| Q2 2013 | $34,000 | – | 673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |